Annika Pasanen
Impact in
-
- Lymphoma Diagnosis and Treatment
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Lymphoma Diagnosis and Treatment 17
- Oncology 14
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 3
- Viral-associated cancers and disorders 3
- Co-authors
- Johanna Myllyharju (4 shared papers)Minna M. Heikkilä (2 shared papers)Kari I. Kivirikko (2 shared papers)Raija T. Sormunen (1 shared paper)Maija Hirsilä (1 shared paper)Sirpa Leppä (10 shared papers)Leo Meriranta (8 shared papers)Amjad Alkodsi (4 shared papers)
In The Last Decade
Annika Pasanen
34 papers receiving 1.6k citations
Annika Pasanen's Hit Papers
Peers
Comparison fields: 5 of 91
- Pathology and Forensic Medicine 657
- Cancer Research 442
- Genetics 258
- Oncology 436
- Immunology 237
Countries citing papers authored by Annika Pasanen
This map shows the geographic impact of Annika Pasanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Pasanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Pasanen more than expected).
Fields of papers citing papers by Annika Pasanen
This network shows the impact of papers produced by Annika Pasanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Pasanen. The network helps show where Annika Pasanen may publish in the future.
Co-authors
The 25 scholars most cited alongside Annika Pasanen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma Hit paper breakdown → | 2017 | 839 |
| 2 | 2011 | 182 | |
| 3 | 2010 | 101 | |
| 4 | 2021 | 99 | |
| 5 | 2011 | 90 | |
| 6 | 2008 | 75 | |
| 7 | 2021 | 46 | |
| 8 | 2020 | 28 | |
| 9 | 2023 | 24 | |
| 10 | 2017 | 23 | |
| 11 | 2019 | 23 | |
| 12 | 2018 | 12 | |
| 13 | 2009 | 10 | |
| 14 | 2020 | 10 | |
| 15 | Will language nests change the direction of language shifts?: On the language nests of Inari Saamis and Karelians | 2010 | 9 |
| 16 | 2018 | 8 | |
| 17 | 2019 | 5 | |
| 18 | 2016 | 4 | |
| 19 | 2016 | 4 | |
| 20 | 2025 | 4 |
About Annika Pasanen
Annika Pasanen is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Cancer Research and Linguistics and Language, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Cancer Genomics and Diagnostics (4 papers), Immune cells in cancer (4 papers), Multilingual Education and Policy (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (657 citations), Cancer Research (442 citations), Genetics (258 citations), Oncology (436 citations) and Immunology (237 citations). Annika Pasanen has collaborated with scholars based in Finland, Denmark and Norway. Frequent co-authors include Johanna Myllyharju, Minna M. Heikkilä, Kari I. Kivirikko, Raija T. Sormunen, Maija Hirsilä, Sirpa Leppä, Leo Meriranta, Amjad Alkodsi, Harald Holte and Marja‐Liisa Karjalainen‐Lindsberg. Their work appears in journals such as Blood, Annals of Oncology, Blood Advances, HemaSphere and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.